The number of deaths related to alcohol use in the US grew by a staggering 25% between 2019 and 2020, the first year of the COVID-19 pandemic.
Academic rigor, journalistic flair
Articles on Opioid epidemic
Displaying 1 - 20 of 61 articles
Drugs can interact with one another in ways that are harmful. A study finds that taking oxycodone with certain SSRIs can make an opioid overdose more likely.
Non-opioid directives allow patients to refuse opioids in all health care settings. For surgical procedures that require anesthesia, however, this may do more harm than good.
Ending the opioid epidemic requires addressing not only treatment gaps in addiction and overdose, but also inadequate pain management.
Fentanyl adulteration led to the replacement of heroin in the unregulated drug supply of British Columbia. Now that benzodiazepines are present in many opioids, are we headed towards a ‘new normal?’
While the COVID-19 pandemic raged on, the opioid epidemic got worse as drug overdose deaths soared. New research proposes a way to chemically modify opioids to reduce the risk of addiction.
From expanding children’s coverage to reducing surprise bills, Biden and lawmakers may be able to broaden health care access.
The 2020 Nobel Prize for Physiology or Medicine goes to the discoverers of the hepatitis C virus. There’s an effective cure but homelessness and the opioid epidemic are driving a surge in infections.
Pharmacists are well positioned to provide communities with a lifesaving drug.
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
About 1 in 4 people prescribed an opioid for pain end up abusing it. New methods to reduce the need for opioids after surgery have been shown to work – and thus minimize the need for such drugs.
Advice from the people who’ve reviewed all the latest evidence about the effectiveness of these painkillers.
While critics accuse companies facing lots of lawsuits of using bankruptcy as a sort of ‘get of jail free card,’ the reality of the legal procedure is more complicated.
State governments are leading the charge against opioid makers over their role in the epidemic. A team of researchers at Penn State examined just how much the crisis has cost them.
A strong link exists among sexual violence, substance use disorder and HIV in women. Why are the women who are most at risk being overlooked?
OxyContin maker Purdue has reportedly been mulling a bankruptcy filling, just as the first of around 2,000 lawsuits against it prepares to go to trial.
Considered in historical context, Purdue’s plan to peddle opioid addiction medicines to vulnerable people is not so surprising. Gilded-Age pharmaceutical companies used similar strategies.
Evidence shows that opioid manufacturers fund patient advocacy groups in Canada, distorting policies to protect public health.
For many who know someone who has lost a loved one, it can be hard to know what to say or how to respond. For those who have lost a loved one, the silence can be deafening. Some things to keep in mind.
The opioid epidemic has hit parts of Appalachia very hard’ places where cancer rates are high. Many patients are surviving cancer treatment only to become addicted.
Top contributors
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Associate Professor of Public Health and Community Medicine; Weiner Hailey Family Professor, Tufts University
-
Professor of Population Health Science, University of Dundee
-
Professor of Social Work, Director of Social Intervention Group, Columbia University
-
Co-Director, Opioid Prescribing Engagement Network and Assistant Professor, University of Michigan
-
Professor of Clinical Neurosciences and Foundation Chair in Physiotherapy, University of South Australia
-
Professor of Criminology, Western Sydney University
-
Professor of Law and Public Health, The Ohio State University
-
Professor of Emergency Medicine and Community Health Sciences, Boston University
-
Associate professor and Co-Director, Center for Drug Safety and Effectiveness, Johns Hopkins University
-
Research data analyst, Johns Hopkins University
-
Johns Hopkins University
-
Professor of Sociology, Suffolk University
-
Associate Professor of Psychology, Indiana University
